Carnegie acted as lead manager in the directed new share issue in Bavarian Nordic Research Institute A/S, a Danish biotechnology company involved in research and development of platform technologies for the production of therapeutic vaccines and gene therapy.June, 2001.
Healthcare
Directed new share issue in Bavarian Nordic Research Institute A/S (DK) — DKK 80 million
June 2001